Huang Jason H, Cullen D Kacy, Browne Kevin D, Groff Robert, Zhang Jun, Pfister Bryan J, Zager Eric L, Smith Douglas H
Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.
Tissue Eng Part A. 2009 Jul;15(7):1677-85. doi: 10.1089/ten.tea.2008.0294.
Although peripheral nerve injury is a common consequence of trauma or surgery, there are insufficient means for repair. In particular, there is a critical need for improved methods to facilitate regeneration of axons across major nerve lesions. Here, we engineered transplantable living nervous tissue constructs to provide a labeled pathway to guide host axonal regeneration. These constructs consisted of stretch-grown, longitudinally aligned living axonal tracts inserted into poly(glycolic acid) tubes. The constructs (allogenic) were transplanted to bridge an excised segment of sciatic nerve in the rat, and histological analyses were performed at 6 and 16 weeks posttransplantation to determine graft survival, integration, and host regeneration. At both time points, the transplanted constructs were found to have maintained their pretransplant geometry, with surviving clusters of graft neuronal somata at the extremities of the constructs spanned by tracts of axons. Throughout the transplanted region, there was an intertwining plexus of host and graft axons, suggesting that the transplanted axons mediated host axonal regeneration across the lesion. By 16 weeks posttransplant, extensive myelination of axons was observed throughout the transplant region. Further, graft neurons had extended axons beyond the margins of the transplanted region, penetrating into the host nerve. Notably, this survival and integration of the allogenic constructs occurred in the absence of immunosuppression therapy. These findings demonstrate the promise of living tissue-engineered axonal constructs to bridge major nerve lesions and promote host regeneration, potentially by providing axon-mediated axonal outgrowth and guidance.
尽管周围神经损伤是创伤或手术的常见后果,但修复手段仍然不足。特别是,迫切需要改进方法以促进轴突在主要神经损伤处的再生。在此,我们构建了可移植的活体神经组织构建体,以提供一条标记路径来引导宿主轴突再生。这些构建体由拉伸生长、纵向排列的活体轴突束插入聚乙醇酸管中组成。将这些构建体(同种异体)移植以桥接大鼠坐骨神经的一段切除部分,并在移植后6周和16周进行组织学分析,以确定移植物的存活、整合及宿主再生情况。在两个时间点,均发现移植的构建体保持了其移植前的形态,在构建体末端有存活的移植物神经元胞体簇,由轴突束跨越。在整个移植区域,宿主和移植物轴突相互交织成丛,表明移植的轴突介导了宿主轴突跨越损伤处的再生。到移植后16周,在整个移植区域观察到轴突广泛髓鞘化。此外,移植物神经元的轴突延伸至移植区域边缘之外,深入宿主神经。值得注意的是,同种异体构建体的这种存活和整合是在没有免疫抑制治疗的情况下发生的。这些发现证明了活体组织工程化轴突构建体在桥接主要神经损伤并促进宿主再生方面的前景,可能是通过提供轴突介导的轴突生长和引导来实现的。